Status:
TERMINATED
Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS
Lead Sponsor:
Beth Israel Deaconess Medical Center
Conditions:
IBS
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To evaluate the effects of VSL#3 on symptoms associated with diarrhea predominant IBS
Detailed Description
The study will evaluate 2 doses of VSL#3 and placebo over a 4 week period in patients presenting with diarrhea predominant IBS symptoms.
Eligibility Criteria
Inclusion
- IBS diarrhea
Exclusion
- \< 18 years of age
- Pregnancy/breast feeding
- concomitant medications to reduce bowel function
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2006
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00179582
Start Date
January 1 2005
End Date
January 1 2006
Last Update
February 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BIDMC
Boston, Massachusetts, United States, 02215